Developer docs
API playgroundTry for free, no card

Search company profiles

Laboratoire Gifrer

Full company profile

uuid000rypk

Namestring
Laboratoire Gifrer
Legal namestring
GIFRER BARBEZAT
Company typeenum
Private
Founded yearint
1912
Descriptiontext

Laboratoire Gifrer (legal entity: GIFRER BARBEZAT) is a French pharmaceutical manufacturer and distributor founded in 1912, organized as a SASU with €7,815,376.73 in share capital and 251-500 employees, headquartered in Vaulx-en-Velin near Lyon. The company develops, manufactures, and distributes a diversified portfolio of CE-marked medical devices, cosmetics, dietary supplements, antiseptic medications, and biocides organized into six categories: pediatrics (sérum physiologique, Mouche Bébé nasal aspirator, MON PREMIER GIFRER baby care, liniment), ORL/respiratory (Physiologica isotonic and hypertonic seawater sprays, Septinasal), women's health (Sorae supplements for menopause, intimate comfort, and menstrual balance), dental care (Bicare+ toothpastes, whitening powders, charcoal-infused bamboo toothbrushes), antisepsis/dermatology (Amukine, modified alcohol, hydrogen peroxide, arnica gel), and gastro-enterology (Carbofen, sodium bicarbonate, glycerin suppositories). Core technical differentiators include pharmaceutical-grade formulation under SASU control, high natural-ingredient percentages (97-99% on the pediatric range), use of seawater from the controlled Cancale Bay zone, and proprietary branded ingredients such as ExceptionHYAL Blossom (hyaluronic acid complex, Roelmi HPC SRL) and Synbæctive (probiotic complex, SYNBALANCE SRL) used in the Sorae line.

The business model is sales-led and B2B2C, distributing primarily through the French pharmacy network (officines) using ACL/CIP-coded SKUs, with secondary direct sales to hospitals and healthcare institutions and direct-to-consumer engagement through e-commerce sites (gifrer.fr, bicare.gifrer.fr). Revenue is generated through one-time sales of physical products across the medical device, cosmetic, food supplement, medication, and biocide categories, with pricing set at the individual pharmacy level and not publicly disclosed by the company. Customer acquisition and retention are reinforced by Club Gifrer, a loyalty/community platform with 50,000+ parent members receiving expert advice, exclusive gifts, and educational content, alongside social media presence on Instagram (@gifrer_france, @bicare_gifrer) and Facebook (Bicare-Gifrer). Core manufacturing of nasal and device products is performed by partner ODOST and STE Pharmaceuticals; web infrastructure is hosted via o2switch (Clermont-Ferrand) and CloudFlare, keeping data and production on French territory.

Short descriptiontext

Laboratoire Gifrer is a French pharmaceutical manufacturer founded in 1912 (legal entity GIFRER BARBEZAT) that develops and distributes CE-marked medical devices, cosmetics, supplements, and antiseptics across pediatric, nasal, women's health, dental, and dermatology categories, sold primarily through French pharmacies to parents, women, and healthcare professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDécines-charpieu, France
HQ citystring
Décines-charpieu
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, baby care products, nasal care solutions, women's health supplements, oral care cosmetics
Industry4 codes
1Baby Bath & Cleansing
CodeCRABAJAAPrimaryYes
2Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening)
CodeCRADAMAAPrimaryNo
3Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
CodeCRADAMADPrimaryNo
4Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryNo
NAICS code1 code
  • Soap and Cleaning Compound Manufacturing32561
SIC code3 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Consumer Healthcare & Personal Care Products
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmaceutical/Medical Device Sales
TypeOne Time License
Description

Sale of CE-marked medical devices including physiological serum, nasal sprays, and nasal aspirators through pharmacy and healthcare professional channels.

gifrer.fr
2Cosmetics
TypeOne Time License
Description

Sale of cosmetic products including baby care, dental care (Bicare+ line), and dermatological products through pharmacy channels.

gifrer.fr
3Dietary Supplements
TypeOne Time License
Description

Sale of food supplements including Sorae women's health line (probiotics, hyaluronic acid) and Carbofen digestive supplements.

gifrer.fr
4Medications
TypeOne Time License
Description

Sale of antiseptic medications (Amukine, modified alcohol, hydrogen peroxide), glycerin suppositories, and other pharmaceutical products.

gifrer.fr
5Biocides
TypeOne Time License
Description

Sale of antiseptic biocides including Septi-Clean sprays and disinfectant wipes for hands and surfaces.

gifrer.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Bicare+
Description

Oral care product line including toothpastes, whitening powders, and toothbrushes under the Gifrer family. Products include dentifrice blancheur bicarbonate, dentifrice blancheur charbon, dentifrice gencives sensibles, and whitening powders.

gifrer.fr
+4 more records
Core offering1 text field

Laboratoire Gifrer (legal entity: GIFRER BARBEZAT) is a French pharmaceutical manufacturer and wholesale distributor founded in 1912. The company produces and sells CE-marked medical devices (physiological serum, nasal sprays, baby nasal aspirators), cosmetics (baby skincare, dental care, dermatological products), dietary supplements (Sorae women's health line, Carbofen), medications (antiseptics, glycerin suppositories), and biocides (Septi-Clean). Products are organized into Pediatrics, Women's Health, Oral Care, ENT/Respiratory, Antisepsis, Dermatology, and Gastro-Enterology categories and distributed primarily through French pharmacies, hospitals, and healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99% natural ingredients on pediatric range (based on 28 products)
+4 more records
Product overview1 text field

Laboratoire Gifrer is a French pharmaceutical company founded in 1912 offering a diversified portfolio of healthcare, cosmetic, and wellness products organized into six main categories: Pediatrics (saline serums, nasal aspirators, baby care cosmetics), ORL/Respiratory (Physiologica nasal sprays, Septinasal products), Women's Health (Sorae supplements, breastfeeding products), Dental Care (Bicare+ oral hygiene line), Antisepsis/Dermatology (antiseptic solutions, traditional skincare), and Gastro-Enterology (Carbofen, sodium bicarbonate). The core medical device portfolio centers on the Physiologica and Septinasal nasal hygiene lines, while the cosmetic portfolio emphasizes natural origin ingredients with products like MON PREMIER GIFRER baby care, liniments, and the Sorae women's health supplement line. The Bicare+ dental sub-brand focuses on natural oral care with whitening toothpastes, powders, and bamboo toothbrushes. The company operates under strict pharmaceutical manufacturing standards with CE marking on medical devices.

Product and service19 records
1Physiologica Nasal Care Range (sérum physiologique and seawater sprays)
CategoryMedical device — nasal hygiene
2Septinasal Nasal Washing Solutions
CategoryMedical device — ENT/respiratory
3Mouche Bébé Nasal Aspirator and Replacement Tips
CategoryMedical device — pediatric
4MON PREMIER GIFRER Baby Skincare Range
CategoryCosmetic — baby care
5Liniment Oléo-Calcaire (400 ml pump and 100 ml)
CategoryCosmetic — baby care
6Crème S.O.S Fesses Rouges (diaper rash cream)
CategoryCosmetic — baby care
7Baby Wipes Range (Calendula, Bio Olive Oil, Auvergne Thermal Water)
CategoryCosmetic — baby care
8Sorae Women's Health Supplements (Ménopause, Confort Intime, Équilibre)
CategoryFood supplement — women's health
9Bicare+ Oral Care Range (toothpastes, whitening powders, bamboo toothbrush)
CategoryCosmetic — oral care
10Carbofen Digestive Supplement
CategoryFood supplement — gastro-enterology
11Antiseptic Solutions Range (Amukine 0.06%, Alcool Modifié 70%, Eau Oxygénée 10V, Dosoxygénée unit doses)
CategoryMedication — antisepsis
12Septi-Clean Biocides (disinfectant wipes and antiseptic spray)
13Glycerin Suppository (Adults)
14Breastfeeding Tisanes (Nature, Citron, Pêche Abricot, Fruits Rouges)
15Traditional Skincare Range (Arnica Gel, Baume Pectoral, Huile d'Amande Douce, Vaseline, Talc de Venise, Andina)
CategoryCosmetic / medication — dermatology
16Pharmaceutical Ingredients and Aids (Glycérine Végétale, Bicarbonate de Sodium)
CategoryPharmaceutical aid / OTC
17Eau Micellaire Bébé and Floral/Aromatic Waters (Bleuet, Fleurs d'Oranger, Rose)
CategoryCosmetic — baby and facial care
18Baume Allaitement (Nipple Balm)
CategoryCosmetic — breastfeeding care
19Essence de Citronnelle 45 ml
CategoryConsumer product — essential oil
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or Integration
Description

ODOST manufactures Physiologica seawater-based nasal spray products that are distributed by Gifrer Barbezat.

Strategic tierCoreTypeTechnology or Integration
Description

STE Pharmaceuticals manufactures various Physiologica nasal care devices and the baby nasal aspirator (Mouche Bébé) distributed by Gifrer Barbezat.

3ExceptionHYAL (Roelmi HPC SRL)
Strategic tierCoreTypeTechnology or Integration
Description

ExceptionHYAL Blossom (hyaluronic acid complex) is a proprietary branded ingredient used in Sorae Ménopause supplements, sourced from Roelmi HPC SRL.

gifrer.fr
4SynbÆctive (SYNBALANCE SRL)
Strategic tierCoreTypeTechnology or Integration
Description

SynbÆctive is a proprietary probiotic complex used in Sorae women's health supplements (Confort Intime and Equilibre), sourced from SYNBALANCE SRL.

gifrer.fr
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pierre Fabre's natural-ingredient personal care brand with a pediatric baby/child range sold through French and international pharmacies. Comparable in clean/natural positioning, pediatric franchise, and pharmacy-led GTM.

2Laboratoire Cooper
TypeDirect peer
Description

French OTC pharmaceutical manufacturer with classic antiseptic, disinfectant, and family medication portfolio (e.g., Biseptine). Overlaps with Gifrer's Amukine, modified alcohol, and Septi-Clean antiseptic/biocide franchises.

TypeDirect peer
Description

Established seawater-based nasal spray brand positioned against Physiologica and Septinasal across European pharmacies and drugstores. Closest direct competitor in the saline nasal hygiene category.

TypeDirect peer
Description

French natural personal care and baby care brand (organic-certified) with comparable high natural ingredient shares across baby cleansing, hygiene, and adult care; competing on the same pharmacy shelves as Gifrer.

TypeDirect peer
Description

French OTC pharmaceutical company with overlapping product lines including saline serums, nasal hygiene (Humer), and antiseptic solutions. Mirrors Gifrer's portfolio breadth across baby care, ORL, and family antiseptics.

TypeEmerging player
Description

French laboratory focused on women's health, weight management, beauty-from-within, and OTC supplements. Comparable channel mix (pharmacies, drugstores) and direct overlap with Sorae menopause/intimate health propositions.

TypeDirect peer
Description

Heritage French baby care brand (talc, liniment, cleansing) now under Johnson & Johnson, sold through French pharmacies with broad pediatric range directly comparable to Gifrer's Mon Premier Gifrer line.

TypeBroad incumbent
Description

Pierre Fabre's dermocosmetic flagship sold predominantly in pharmacies, with broader dermatology, baby, and sensitive-skin ranges. Larger incumbent peer with broader portfolio but overlapping pharmacy-led, dermatologist-validated positioning.

TypeEmerging player
Description

French specialist in microbiome, women's health, and dietary supplements distributed through pharmacies and healthcare professionals. Direct competitor to the Sorae women's health supplement line, particularly on intimate and menopausal indications.

TypeDirect peer
Description

French family-owned dermocosmetics and baby care specialist, distributed primarily through pharmacies and healthcare professionals. Closest analogue to Gifrer's pediatric positioning, natural-ingredient narrative, and B2B2C pharmacy channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laboratoire Gifrer

Consumer Healthcare & Personal Care Productsgifrer.fr

Laboratoire Gifrer is a French pharmaceutical manufacturer founded in 1912 (legal entity GIFRER BARBEZAT) that develops and distributes CE-marked medical devices, cosmetics, supplements, and antiseptics across pediatric, nasal, women's health, dental, and dermatology categories, sold primarily through French pharmacies to parents, women, and healthcare professionals.

What Laboratoire Gifrer does

Laboratoire Gifrer (legal entity: GIFRER BARBEZAT) is a French pharmaceutical manufacturer and distributor founded in 1912, organized as a SASU with €7,815,376.73 in share capital and 251-500 employees, headquartered in Vaulx-en-Velin near Lyon. The company develops, manufactures, and distributes a diversified portfolio of CE-marked medical devices, cosmetics, dietary supplements, antiseptic medications, and biocides organized into six categories: pediatrics (sérum physiologique, Mouche Bébé nasal aspirator, MON PREMIER GIFRER baby care, liniment), ORL/respiratory (Physiologica isotonic and hypertonic seawater sprays, Septinasal), women's health (Sorae supplements for menopause, intimate comfort, and menstrual balance), dental care (Bicare+ toothpastes, whitening powders, charcoal-infused bamboo toothbrushes), antisepsis/dermatology (Amukine, modified alcohol, hydrogen peroxide, arnica gel), and gastro-enterology (Carbofen, sodium bicarbonate, glycerin suppositories). Core technical differentiators include pharmaceutical-grade formulation under SASU control, high natural-ingredient percentages (97-99% on the pediatric range), use of seawater from the controlled Cancale Bay zone, and proprietary branded ingredients such as ExceptionHYAL Blossom (hyaluronic acid complex, Roelmi HPC SRL) and Synbæctive (probiotic complex, SYNBALANCE SRL) used in the Sorae line.

The business model is sales-led and B2B2C, distributing primarily through the French pharmacy network (officines) using ACL/CIP-coded SKUs, with secondary direct sales to hospitals and healthcare institutions and direct-to-consumer engagement through e-commerce sites (gifrer.fr, bicare.gifrer.fr). Revenue is generated through one-time sales of physical products across the medical device, cosmetic, food supplement, medication, and biocide categories, with pricing set at the individual pharmacy level and not publicly disclosed by the company. Customer acquisition and retention are reinforced by Club Gifrer, a loyalty/community platform with 50,000+ parent members receiving expert advice, exclusive gifts, and educational content, alongside social media presence on Instagram (@gifrer_france, @bicare_gifrer) and Facebook (Bicare-Gifrer). Core manufacturing of nasal and device products is performed by partner ODOST and STE Pharmaceuticals; web infrastructure is hosted via o2switch (Clermont-Ferrand) and CloudFlare, keeping data and production on French territory.

Laboratoire Gifrer firmographics

Firmographics
Name
Laboratoire Gifrer
Legal name
GIFRER BARBEZAT
Website
https://www.gifrer.fr/
Company type
Private
Founded year
1912
Operating status
Operating
Headcount range
101–250 employees
Short description
Laboratoire Gifrer is a French pharmaceutical manufacturer founded in 1912 (legal entity GIFRER BARBEZAT) that develops and distributes CE-marked medical devices, cosmetics, supplements, and antiseptics across pediatric, nasal, women's health, dental, and dermatology categories, sold primarily through French pharmacies to parents, women, and healthcare professionals.
Ownership category
akta.pro rank

Laboratoire Gifrer industry classification

Industry
Product category
Consumer Healthcare & Personal Care Products
NAICS
Soap and Cleaning Compound Manufacturing (32561)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Baby Bath & Cleansing (CRABAJAA)
akta.pro secondary industries
Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

  • Pharmaceutical manufacturing
  • Baby care products
  • Nasal care solutions
  • Women's health supplements
  • Oral care cosmetics

Where Laboratoire Gifrer is headquartered

Location

Headquarters

HQ city
Décines-charpieu
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Laboratoire Gifrer business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical/Medical Device Sales: Sale of CE-marked medical devices including physiological serum, nasal sprays, and nasal aspirators through pharmacy and healthcare professional channels.
  2. Cosmetics: Sale of cosmetic products including baby care, dental care (Bicare+ line), and dermatological products through pharmacy channels.
  3. Dietary Supplements: Sale of food supplements including Sorae women's health line (probiotics, hyaluronic acid) and Carbofen digestive supplements.
  4. Medications: Sale of antiseptic medications (Amukine, modified alcohol, hydrogen peroxide), glycerin suppositories, and other pharmaceutical products.
  5. Biocides: Sale of antiseptic biocides including Septi-Clean sprays and disinfectant wipes for hands and surfaces.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Laboratoire Gifrer product offering

Product offering

Core offering

Laboratoire Gifrer (legal entity: GIFRER BARBEZAT) is a French pharmaceutical manufacturer and wholesale distributor founded in 1912. The company produces and sells CE-marked medical devices (physiological serum, nasal sprays, baby nasal aspirators), cosmetics (baby skincare, dental care, dermatological products), dietary supplements (Sorae women's health line, Carbofen), medications (antiseptics, glycerin suppositories), and biocides (Septi-Clean). Products are organized into Pediatrics, Women's Health, Oral Care, ENT/Respiratory, Antisepsis, Dermatology, and Gastro-Enterology categories and distributed primarily through French pharmacies, hospitals, and healthcare professionals.

Product overview

Laboratoire Gifrer is a French pharmaceutical company founded in 1912 offering a diversified portfolio of healthcare, cosmetic, and wellness products organized into six main categories: Pediatrics (saline serums, nasal aspirators, baby care cosmetics), ORL/Respiratory (Physiologica nasal sprays, Septinasal products), Women's Health (Sorae supplements, breastfeeding products), Dental Care (Bicare+ oral hygiene line), Antisepsis/Dermatology (antiseptic solutions, traditional skincare), and Gastro-Enterology (Carbofen, sodium bicarbonate). The core medical device portfolio centers on the Physiologica and Septinasal nasal hygiene lines, while the cosmetic portfolio emphasizes natural origin ingredients with products like MON PREMIER GIFRER baby care, liniments, and the Sorae women's health supplement line. The Bicare+ dental sub-brand focuses on natural oral care with whitening toothpastes, powders, and bamboo toothbrushes. The company operates under strict pharmaceutical manufacturing standards with CE marking on medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Bicare+: Oral care product line including toothpastes, whitening powders, and toothbrushes under the Gifrer family. Products include dentifrice blancheur bicarbonate, dentifrice blancheur charbon, dentifrice gencives sensibles, and whitening powders.
  • Physiologica
  • Septinasal
  • Sorae
  • MON PREMIER GIFRER

Products and services

  • Physiologica Nasal Care Range (sérum physiologique and seawater sprays)
  • Septinasal Nasal Washing Solutions
  • Mouche Bébé Nasal Aspirator and Replacement Tips
  • MON PREMIER GIFRER Baby Skincare Range
  • Liniment Oléo-Calcaire (400 ml pump and 100 ml)
  • Crème S.O.S Fesses Rouges (diaper rash cream)
  • Baby Wipes Range (Calendula, Bio Olive Oil, Auvergne Thermal Water)
  • Sorae Women's Health Supplements (Ménopause, Confort Intime, Équilibre)
  • Bicare+ Oral Care Range (toothpastes, whitening powders, bamboo toothbrush)
  • Carbofen Digestive Supplement
  • Antiseptic Solutions Range (Amukine 0.06%, Alcool Modifié 70%, Eau Oxygénée 10V, Dosoxygénée unit doses)
  • Septi-Clean Biocides (disinfectant wipes and antiseptic spray)
  • Glycerin Suppository (Adults)
  • Breastfeeding Tisanes (Nature, Citron, Pêche Abricot, Fruits Rouges)
  • Traditional Skincare Range (Arnica Gel, Baume Pectoral, Huile d'Amande Douce, Vaseline, Talc de Venise, Andina)
  • Pharmaceutical Ingredients and Aids (Glycérine Végétale, Bicarbonate de Sodium)
  • Eau Micellaire Bébé and Floral/Aromatic Waters (Bleuet, Fleurs d'Oranger, Rose)
  • Baume Allaitement (Nipple Balm)
  • Essence de Citronnelle 45 ml

Quantifiable outcome

  • 99% natural ingredients on pediatric range (based on 28 products)
  • +4 more outcomes

Companies that use Laboratoire Gifrer

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Laboratoire Gifrer technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Laboratoire Gifrer partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • ODOSTcoreTechnology or IntegrationODOST manufactures Physiologica seawater-based nasal spray products that are distributed by Gifrer Barbezat.
  • STE PharmaceuticalscoreTechnology or IntegrationSTE Pharmaceuticals manufactures various Physiologica nasal care devices and the baby nasal aspirator (Mouche Bébé) distributed by Gifrer Barbezat.
  • ExceptionHYAL (Roelmi HPC SRL)coreTechnology or IntegrationExceptionHYAL Blossom (hyaluronic acid complex) is a proprietary branded ingredient used in Sorae Ménopause supplements, sourced from Roelmi HPC SRL.
  • SynbÆctive (SYNBALANCE SRL)coreTechnology or IntegrationSynbÆctive is a proprietary probiotic complex used in Sorae women's health supplements (Confort Intime and Equilibre), sourced from SYNBALANCE SRL.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Laboratoire Gifrer competitors and assessment

Company assessment

Direct peers

  • Klorane (Pierre Fabre): Pierre Fabre's natural-ingredient personal care brand with a pediatric baby/child range sold through French and international pharmacies. Comparable in clean/natural positioning, pediatric franchise, and pharmacy-led GTM.
  • Laboratoire Cooper: French OTC pharmaceutical manufacturer with classic antiseptic, disinfectant, and family medication portfolio (e.g., Biseptine). Overlaps with Gifrer's Amukine, modified alcohol, and Septi-Clean antiseptic/biocide franchises.
  • Stérimar: Established seawater-based nasal spray brand positioned against Physiologica and Septinasal across European pharmacies and drugstores. Closest direct competitor in the saline nasal hygiene category.
  • Cattier Paris: French natural personal care and baby care brand (organic-certified) with comparable high natural ingredient shares across baby cleansing, hygiene, and adult care; competing on the same pharmacy shelves as Gifrer.
  • Laboratoires Gilbert: French OTC pharmaceutical company with overlapping product lines including saline serums, nasal hygiene (Humer), and antiseptic solutions. Mirrors Gifrer's portfolio breadth across baby care, ORL, and family antiseptics.
  • Biolane (Johnson & Johnson): Heritage French baby care brand (talc, liniment, cleansing) now under Johnson & Johnson, sold through French pharmacies with broad pediatric range directly comparable to Gifrer's Mon Premier Gifrer line.
  • Mustela (Laboratoires Expanscience): French family-owned dermocosmetics and baby care specialist, distributed primarily through pharmacies and healthcare professionals. Closest analogue to Gifrer's pediatric positioning, natural-ingredient narrative, and B2B2C pharmacy channel.

Emerging players

  • Forté Pharma: French laboratory focused on women's health, weight management, beauty-from-within, and OTC supplements. Comparable channel mix (pharmacies, drugstores) and direct overlap with Sorae menopause/intimate health propositions.
  • PiLeJe: French specialist in microbiome, women's health, and dietary supplements distributed through pharmacies and healthcare professionals. Direct competitor to the Sorae women's health supplement line, particularly on intimate and menopausal indications.

Broad incumbents

  • Avène (Pierre Fabre): Pierre Fabre's dermocosmetic flagship sold predominantly in pharmacies, with broader dermatology, baby, and sensitive-skin ranges. Larger incumbent peer with broader portfolio but overlapping pharmacy-led, dermatologist-validated positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Laboratoire Gifrer social profiles

Digital presence

Laboratoire Gifrer compliance and trust

Trust signal

Compliance3 records

Laboratoire Gifrer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laboratoire Gifrer leadership team

Management profile

Number of profiles

Laboratoire Gifrer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laboratoire Gifrer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Gifrer

What does Laboratoire Gifrer do?

Laboratoire Gifrer (legal entity: GIFRER BARBEZAT) is a French pharmaceutical manufacturer and wholesale distributor founded in 1912. The company produces and sells CE-marked medical devices (physiological serum, nasal sprays, baby nasal aspirators), cosmetics (baby skincare, dental care, dermatological products), dietary supplements (Sorae women's health line, Carbofen), medications (antiseptics, glycerin suppositories), and biocides (Septi-Clean). Products are organized into Pediatrics, Women's Health, Oral Care, ENT/Respiratory, Antisepsis, Dermatology, and Gastro-Enterology categories and distributed primarily through French pharmacies, hospitals, and healthcare professionals.

Is Laboratoire Gifrer a public or private company?

Laboratoire Gifrer is a private company. It is classified as family owned and is currently operating.

When was Laboratoire Gifrer founded?

Laboratoire Gifrer was founded in 1912. It employs 101 to 250 people.

Where is Laboratoire Gifrer based?

Laboratoire Gifrer is headquartered in Décines-charpieu, France, in the Europe region.

How does Laboratoire Gifrer make money?

Five revenue lines are on record. Pharmaceutical/Medical Device Sales are the primary driver. The others are cosmetics, dietary Supplements, medications and biocides.

Who are Laboratoire Gifrer's main competitors?

Direct peers on record are Klorane (Pierre Fabre), Laboratoire Cooper, Stérimar, Cattier Paris, Laboratoires Gilbert, Biolane (Johnson & Johnson) and Mustela (Laboratoires Expanscience). Emerging players are Forté Pharma and PiLeJe. Avène (Pierre Fabre) is listed as a broad incumbent.

Does Laboratoire Gifrer have an API?

No public API is recorded for Laboratoire Gifrer.

What industry is Laboratoire Gifrer in?

Laboratoire Gifrer's product category is Consumer Healthcare & Personal Care Products. Its primary akta.pro industry code is CRABAJAA, Baby Bath & Cleansing, with a secondary code of CRADAMAA, Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening). Its NAICS code is 32561 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BusinesskoreaCelltrion Completes Gifrer Integration in FranceCelltrion has completed the post-acquisition integration of French healthcare company Gifrer, securing access to a pharmacy network of approximately 9,000 outlets and a hospital supply chain covering 800 facilities. The company plans to leverage this distribution infrastructure to launch direct sales of its biopharmaceuticals, such as Stoboclo-Osenvelt, and expand into selling third-party products and dermo-cosmetics like Zipiderm in the European market.KoreatimesCelltrion set to ramp up pharmacy biz in France with Gifrer acquisitionCelltrion has completed the integration of French healthcare company Gifrer and plans to leverage its pharmacy sales network to boost the distribution of its biosimilar products in France. The Korean biopharmaceutical group acquired full ownership of Gifrer in May, utilizing the latter's access to over 9,000 pharmacies to address gaps in its direct sales capabilities for subcutaneous injectable drugs.BiggoCelltrion Completes Gifrer Integration, Accelerates Push into 9,000 European Pharmacies — BigGo FinanceCelltrion completed post-merger integration of French healthcare firm Gifrer, acquired in May, and is expanding its European pharmacy channel. The company will combine Gifrer's network of over 9,000 pharmacies with its hospital-focused direct sales to sell subcutaneous products and biosimilars, starting with Stoboclo-Osenvelt. France will serve as a testbed for phased expansion across Europe.KBRCelltrion eyes Europe-wide pharmacy sales after integrating France’s GifrerCelltrion has completed the integration of French healthcare company Gifrer, acquired in May, to establish a pharmacy-based sales channel for biologics and other products in France. The strategy involves leveraging Gifrer's network of over 9,000 pharmacies to distribute Celltrion's biosimilars and third-party products, serving as a test bed for potential expansion across Europe.CelltrionCelltrion Acquires French Healthcare Company Gifrer to Strengthen Its Position in EuropeCelltrion acquired French healthcare company Gifrer to strengthen its presence in France's pharmacy channel. The deal is expected to generate over KRW 250 billion in additional revenue over five years, leveraging Gifrer's network of 9,000 pharmacies. Celltrion plans to cross-sell Gifrer's OTC products across EU5 markets.